EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatic Steatosis in People With Chronic Hepatitis B in Africa: Prevalence, Correlates, and Clinical Significance

Freeman W Chabala iD, Edford Sinkala iD, Alana T Brennan iD, Amy Miskimon Goss iD, Lamin Bojang, Yusupha Samateh, Alexander J Stockdale iD, Roger Sombie iD, Arouna Sessouma, Alice Nanelin Guingane iD, Juste Aristide Goungounga iD, Mohamed El-Kassas und 16 weitere

Journal of Viral Hepatitis · 2026

DOI: 10.1111/jvh.70241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2026. Verfasst von Freeman W Chabala und 27 weiteren Autor:innen. Beteiligte Einrichtung: Levy Mwanawasa Medical University, Lusaka, Zambia. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Fatty Liver. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NIDDK NIH HHS, John C. Martin Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To address data gaps around metabolic liver disease in Africa, within the Hepatitis B in Africa Collaborative Network (HEPSANET), we evaluated participants with chronic hepatitis B virus infection (CHB) for steatotic liver disease (SLD) using transient elastography with controlled attenuation parameter (CAP). Using multivariable logistic regression, we identified sociodemographic, anthropometric, and clinical associations with SLD (CAP ≥ 248 dB/m), and evaluated whether SLD severity was independently associated with fibrosis. Short‐term impacts of SLD on mortality were also assessed with Cox proportional hazards analysis. We also evaluated the diagnostic performance of B‐mode ultrasound for SLD, with CAP as reference. Across 6 countries and 1601 participants (age range, 12–80 years; 39.5% female; 4% with diabetes; 11% unhealthy alcohol use; median body mass index, 24.4), 421 (26.3%) had SLD; 219 (13.7%) had severe steatosis (CAP ≥ 280 dB/m). Older age, male sex, overweight and obesity, and HIV‐negative status were associated with SLD. After adjusting for age, sex, HIV status, HBV treatment, and country, severe steatosis, but not mild and moderate forms (i.e., 248–279 dB/m), was associated with a 8.4% (95%, 1.9%–14.9%) increased probability of fibrosis. Over limited follow‐up (median 2.69 years) and small number of deaths, SLD was not associated with all‐cause or liver‐related mortality. B‐mode ultrasound had low sensitivity for SLD, overall or when severe, but specificity was 95%. In conclusion, SLD was common in people with CHB in Africa and its severe form was associated with liver fibrosis. These data support screening for metabolic comorbidities as part of HBV care and treatment in Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicFatty LiverHumansFemaleMalePrevalenceAdolescentMiddle AgedAdultAfricaYoung AdultAged, 80 and overChildAgedElasticity Imaging TechniquesLiver Cirrhosis

Stichwörter der Autor:innen

AfricaHBV/HIV coinfectionchronic HBV infectionliver fibrosissteatosis

Autor:innen und Institutionen

  • Levy Mwanawasa Medical University, Lusaka, Zambia.
  • Department of Medicine, University of Zambia, Lusaka, Zambia.
  • Department of Global Health and Epidemiology, Boston University, Boston, USA.
  • Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, USA.
  • The Medical Research Council Unit the Gambia, London School of Hygiene & Tropical Medicine, Fajara, The Gambia.

ORCID-Profile: Freeman W Chabala, Edford Sinkala, Alana T Brennan, Amy Miskimon Goss, Alexander J Stockdale, Roger Sombie, Alice Nanelin Guingane, Juste Aristide Goungounga, Eman Marwan, Ibrahima Diallo, Edith Okeke, Hans Prozesky, Mark Sonderup, C Wendy Spearman, Philippa C Matthews, Judicaël Malick Tine, Maud Lemoine, Hailemichael Desalegn Mekonnen, Asgeir Johnannessen, Michael J Vinikoor

Förderung

  • Medical Research Council
  • NIDDK NIH HHS
  • John C. Martin Foundation
  • Cancer Research UK
  • European Association for the Study of the Liver
  • NIAID NIH HHS
  • NIH HHS
  • FIC NIH HHS

Zitieren

APA

Chabala, F. W., Sinkala, E., Brennan, A. T., Goss, A. M., Bojang, L., Samateh, Y., Stockdale, A. J., Sombie, R., Sessouma, A., Guingane, A. N., Goungounga, J. A., El-Kassas, M., Marwan, E., Diallo, I., Sow, A., Okeke, E., Okwute, A., Prozesky, H., Ismail, Z., …, & Hepatitis B in Africa Collaborative Network (HEPSANET) (2026). Hepatic Steatosis in People With Chronic Hepatitis B in Africa: Prevalence, Correlates, and Clinical Significance. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70241

Vancouver

Chabala FW, Sinkala E, Brennan AT, Goss AM, Bojang L, Samateh Y, et al. Hepatic Steatosis in People With Chronic Hepatitis B in Africa: Prevalence, Correlates, and Clinical Significance. Journal of Viral Hepatitis. 2026. doi:10.1111/jvh.70241

BibTeX
@article{Chabala2026,
  author = {Chabala, Freeman W and Sinkala, Edford and Brennan, Alana T and Goss, Amy Miskimon and Bojang, Lamin and Samateh, Yusupha and Stockdale, Alexander J and Sombie, Roger and Sessouma, Arouna and Guingane, Alice Nanelin and Goungounga, Juste Aristide and El-Kassas, Mohamed and Marwan, Eman and Diallo, Ibrahima and Sow, Abdoul and Okeke, Edith and Okwute, Attah and Prozesky, Hans and Ismail, Zahiera and Sonderup, Mark and Spearman, C Wendy and Matthews, Philippa C and Tine, Judicaël Malick and Lemoine, Maud and Mekonnen, Hailemichael Desalegn and Johnannessen, Asgeir and Vinikoor, Michael J and Hepatitis B in Africa Collaborative Network (HEPSANET), Hepatitis B in Africa Collaborative Network (HEPSANET)},
  title = {Hepatic Steatosis in People With Chronic Hepatitis B in Africa: Prevalence, Correlates, and Clinical Significance},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  doi = {10.1111/jvh.70241}
}
Kostenlos starten →